Work

Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells

Year: 2014

Type: article

Source: Nanomedicine Nanotechnology Biology and Medicine

DOI: 10.1016/j.nano.2014.07.013

Authors: Eun-Ju Ko, Young-Man Kwon, Jong Seok Lee, Hye Suk Hwang, Si-Eun Yoo, Yu-Na Lee, Young-Tae Lee, Min-Chul Kim, Min Kyoung Cho, You Ri Lee, Fu-Shi Quan, Jae-Min Song, Sujin Lee, Martin L. Moore, Sang-Moo Kang

Institutions: Georgia State University, Animal and Plant Quarantine Agency, Kyung Hee University, Sungshin Women's University, Emory University, Children's Healthcare of Atlanta

Language: English

Topic: Respiratory viral infections research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Georgia Research Alliance, National Institutes of Health, National Institute of Allergy and Infectious Diseases

Awards: VLP Vaccine Technology, Role of the Respiratory Syncytial Virus Fusion Protein in Airway Mucus Induction, Influenza vaccines inducing broadly cross protective immunity, Viral and Host Determinants of Infant and Childhood Allergy and Asthma

OpenAlex ID: W2024906191

FWCI: 3.603

Cites: 49

Cited by: 31

Related to: 10